
Standard Chartered Joins China's Digital Yuan Trials, Eyes Cross-Border Payments
Nov 28, 2023 08:37 am UTC| Business Digital Currency Investing Fintech
Standard Chartered has announced its participation in the trials of Chinas digital yuan central bank digital currency (CBDC), known as the e-CNY. This move made Standard Chartered one of the first foreign banks to conduct...

IHOP Unveils Wonka-Themed Menu for Limited Time; Celebrates New Movie Release
Nov 28, 2023 08:14 am UTC| Business
IHOP, or International House of Pancakes, continues to expand its menu by adding new categories for special occasions. In this holiday season, the restaurant revealed a new food lineup to celebrate Warner Bros.s release of...

Google to Delete Inactive Accounts: Time to Act!
Nov 28, 2023 07:07 am UTC| Business Technology
Google, the global tech giant, is taking a proactive step towards bolstering online security. To prevent security risks and safeguard user data, the company will commence deleting inactive Google accounts this...

Jack Ma Enters Food Business, Launches Ma’s Kitchen in China
Nov 28, 2023 07:04 am UTC| Business
Jack Ma reportedly invested $1.4 million to enter the food business. The Alibaba founder opened a food processing company simply called Mas Kitchen. The launch of his new business comes amid the wide tech crackdown in...

Burger King UK Welcomes Lance Batchelor as New Chair for Strategic Growth
Nov 28, 2023 06:43 am UTC| Business
Burger King UK has announced the appointment of Lance Batchelor as the companys new Chair. With his extensive experience in the industry, Batchelor is well-positioned to drive growth and success for the popular fast-food...

OKX Expands Services, Adds Crypto Exchange and Wallet Platform in Brazil
Nov 28, 2023 06:35 am UTC| Business Digital Currency Investing
OKX announced it has expanded its service offerings in Brazil by adding a cryptocurrency exchange and a digital wallet. The Web3 developer said that through the launch of these new services in the country, it will also...

GSK's Pulled Myeloma Drug Outperforms J&J's Darzalex in Key Trial
Nov 28, 2023 06:24 am UTC| Business Health
A multiple myeloma drug withdrawn from the market by GSK has now demonstrated positive results in a pivotal trial, surpassing a rival product by Johnson Johnson. These findings lay the groundwork for a potential comeback...